These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3621107)

  • 1. Acute arrhythmogenicity of doxorubicin administration.
    Steinberg JS; Cohen AJ; Wasserman AG; Cohen P; Ross AM
    Cancer; 1987 Sep; 60(6):1213-8. PubMed ID: 3621107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of first-dose doxorubicin on cardiac rhythm as evaluated by continuous 24-hour monitoring.
    Friess GG; Boyd JF; Geer MR; Garcia JC
    Cancer; 1985 Dec; 56(12):2762-4. PubMed ID: 4052950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac arrhythmias in patients with small cell lung cancer and cardiac disease before, during and after doxorubicin administration. An evaluation of acute cardiotoxicity by continuous 24-hour Holter monitoring.
    Raabe NK; Storstein L
    Acta Oncol; 1991; 30(7):843-6. PubMed ID: 1662523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute arrhythmogenicity of first-dose chemotherapeutic agents in children.
    Massin MM; Dresse MF; Schmitz V; Hoyoux C; Chantraine JM; Lepage P
    Med Pediatr Oncol; 2002 Aug; 39(2):93-8. PubMed ID: 12116056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late arrhythmogenic effects of doxorubicin.
    Kilickap S; Barista I; Akgul E; Aytemir K; Aksoy S; Tekuzman G
    South Med J; 2007 Mar; 100(3):262-5. PubMed ID: 17396729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early cardiac toxicity of 4'-iodo-4'-deoxydoxorubicin.
    Villani F; Galimberti M; Comazzi R
    Eur J Cancer; 1991; 27(12):1601-4. PubMed ID: 1782067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute doxorubicin-induced cardiac arrhythmias during ether anesthesia.
    Aversano RC; Boor PJ
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):345-8. PubMed ID: 6635326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ECG changes in adriamycin therapy].
    Pötzi P; Huber J; Kühböck J; Weber H
    Acta Med Austriaca Suppl; 1979; 6():339-41. PubMed ID: 299225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthermia potentiates doxorubicin-related cardiotoxic effects.
    Kim YD; Lees DE; Lake CR; Whang-Peng J; Schuette W; Smith R; Bull J
    JAMA; 1979 Apr; 241(17):1816-7. PubMed ID: 430749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac arrhythmias due to oral aminophylline in patients with chronic obstructive pulmonary disease.
    Patel AK; Skatrud JB; Thomsen JH
    Chest; 1981 Dec; 80(6):661-5. PubMed ID: 7307587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and ventricular arrhythmia.
    Cosgriff TM
    Ann Intern Med; 1980 Mar; 92(3):434-5. PubMed ID: 7356243
    [No Abstract]   [Full Text] [Related]  

  • 14. Sudden death during doxorubicin administration.
    Wortman JE; Lucas VS; Schuster E; Thiele D; Logue GL
    Cancer; 1979 Nov; 44(5):1588-91. PubMed ID: 291473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide exposure of subjects with documented cardiac arrhythmias.
    Chaitman BR; Dahms TE; Byers S; Carroll LW; Younis LT; Wiens RD
    Res Rep Health Eff Inst; 1992 Sep; (52):1-26; discussion 27-37. PubMed ID: 1418771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of the effect of I.V. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients.
    Girgis I; Gualberti J; Langan L; Malek S; Mustaciuolo V; Costantino T; McGinn TG
    Chest; 1997 Sep; 112(3):646-53. PubMed ID: 9315796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.
    Wilcox RG; Eastgate J; Harrison E; Skene AM
    Br Heart J; 1991 Jan; 65(1):4-8. PubMed ID: 1899582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.
    Alexopoulos D; Collins R; Adamopoulos S; Peto R; Sleight P
    Br Heart J; 1991 Jan; 65(1):9-13. PubMed ID: 1993133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.